Related Research Articles
Pharmaceutical Research and Manufacturers of America, formerly known as the Pharmaceutical Manufacturers Association, is a trade group representing companies in the pharmaceutical industry in the United States. Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. PhRMA is headquartered in Washington, DC.
Bausch Health Companies Inc. is a Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products.
Perrigo Company plc is an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the 6th-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes.
Ruane, Cunniff & Goldfarb, based in New York City, is the investment firm founded in 1969 by William J. Ruane, Richard T. Cunniff and Robert Goldfarb.
Robert Goldfarb serves as president and CEO of Ruane, Cunniff & Goldfarb, the value investing firm founded in 1970 by William J. Ruane and Rick Cunniff. Goldfarb is a disciple of Warren Buffett, the CEO of Berkshire Hathaway. A native of St. Louis, Goldfarb received his B.A. from Yale University in 1967, where he graduated summa cum laude and Phi Beta Kappa, and went on to earn his M.B.A. from Harvard Business School in 1971. In 2010, Goldfarb and David Poppe were selected as Domestic-Stock mutual fund managers of the year by Morningstar, Inc. for the outstanding long-term performance of the Sequoia Fund.
Actavis Generics is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.
Jeffrey B. Kindler is an American healthcare executive and private investor. He served as chairman and CEO of the pharmaceutical company Pfizer from 2006 to 2010. Kindler has later served as CEO of Centrexion Inc., and chairman of the GLG Institute.
Medicis Pharmaceutical is a medical cosmetics company based in Bridgewater, New Jersey. It is a subsidiary of Valeant Pharmaceuticals, which acquired the company in 2012. Medicis is known for products such as Solodyn and Ziana for treating acne, and for Restylane and Dysport for treating facial wrinkles.
J. Michael Pearson is a Canadian American pharmaceutical company executive. He is the former chairman and CEO of Valeant Pharmaceuticals International after being ousted in the aftermath of a report on pharmaceutical pricing published by Citron Research in April 2016.
Alex Gorsky is the Executive Chairman of Johnson & Johnson. He is the seventh person who served as chair and CEO of Johnson & Johnson since it became a publicly traded company in 1944.
Andrew Edward Left is an activist, short seller, author and editor of the online investment newsletter Citron Research, formerly StockLemon.com. Under the name Citron Research, Left publishes reports on firms that he claims are overvalued or are engaged in fraud. Left is known for advising investors on short selling and has often appeared on various media outlets such as CNBC and Bloomberg to talk about his opinions on stocks. In 2017, Left was called 'The Bounty Hunter of Wall Street' by The New York Times. Left gained further notoriety following his announced short of GameStop, precipitating a short squeeze that has hurt him and other short sellers in the short term.
John C. Lechleiter is an American businessman and chemist. He served as the President, Chief Executive Officer and Chairman of the Board of Directors of Eli Lilly and Company from April 2008 to December 2016. John Lechleiter's successor is David Ricks who assumed the role of president and CEO in January 2017. He is the eldest of nine children of Jeanne and John H. Lechleiter.
David Edmund Ian Pyott was the CEO of Allergan, a pharmaceutical company from 1998 to 2015, when Allergan was acquired by Actavis. In 2014 he was one of the 25 highest-paid CEOs in the United States.
Joseph C. Papa is an American businessman, the chairman and chief executive officer (CEO) of Bausch Health from May 2, 2016 succeeding J. Michael Pearson.
David Ebsworth is non-executive chairman at Verona Pharma Plc. His career spans over 35 years in the global pharmaceutical industry, during which he was Global Head of Pharmaceuticals at Bayer AG and CEO of a number of companies, including ViforPharma and Galenica. He is also an advisor to a variety of CEOs at public and private organisations.
Cindy Eckert is an American entrepreneur known for founding Sprout Pharmaceuticals. She subsequently founded The Pink Ceiling which invests in companies founded by, or delivering products for, women. In November 2017, Eckert re-acquired Sprout Pharmaceuticals as part of a lawsuit settlement, and the rights to its drug Addyi, from Valeant after Valeant's stock collapsed due to insider trading and price jacking allegations.
Jeffrey Chad Smith or Jeff Smith, is an American hedge fund manager who headed Starboard Value since April 2011. In 2014, William Cohan of Fortune called Smith "[t]he most feared man in corporate America."
Jonah Shacknai is a pharmaceutical executive. He was the founder of Illustris Pharmaceuticals and was the founder, chairman and CEO of Medicis Pharmaceutical Corporation. He also served as Chief Aide to the US House of Representative's committee for health policy.
References
- 1 2 "Perrigo Executive Management". Perrigo.com. Retrieved 2016-05-12.
- ↑ "Stocks". Bloomberg. Retrieved 2016-05-12.
- ↑ "Valeant names Papa CEO after he resigns from Perrigo". Reuters. 2016-04-25. Retrieved 2016-05-12.
- ↑ "Valeant: Joseph Papa Joins Pharmaceutical Company As Chief Exec As Perrigo Names Hendrickson New CEO". Ibtimes.com. 2015-11-09. Retrieved 2016-05-12.
 | This article about a chief executive from the United States is a stub. You can help Wikipedia by expanding it. |